Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 分子醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46358
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor莊立民(Lee-Ming Chuang)
dc.contributor.authorShan-Shan Kuoen
dc.contributor.author郭珊珊zh_TW
dc.date.accessioned2021-06-15T05:05:13Z-
dc.date.available2015-09-09
dc.date.copyright2010-09-09
dc.date.issued2010
dc.date.submitted2010-07-27
dc.identifier.citation參考文獻
1. Zimmet, P., K.G. Alberti, and J. Shaw, Global and societal implications of the diabetes epidemic. Nature, 2001. 414(6865): p. 782-7.
2. Chang, C., et al., Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract, 2000. 50 Suppl 2: p. S49-59.
3. Chan, J.C., et al., Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA, 2009. 301(20): p. 2129-40.
4. Adeghate, E., P. Schattner, and E. Dunn, An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci, 2006. 1084: p. 1-29.
5. Liu, P.H., et al., Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults. J Clin Endocrinol Metab, 2009. 94(9): p. 3575-82.
6. Zeggini, E., et al., Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet, 2008. 40(5): p. 638-45.
7. Saxena, R., et al., Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science, 2007. 316(5829): p. 1331-6.
8. Scott, L.J., et al., A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 2007. 316(5829): p. 1341-5.
9. Zeggini, E., et al., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science, 2007. 316(5829): p. 1336-41.
10. Steinthorsdottir, V., et al., A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet, 2007. 39(6): p. 770-5.
11. Chang, Y.C., et al., Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes, 2007. 56(10): p. 2631-7.
12. Chang, Y.C., et al., Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. Diabetes, 2008. 57(8): p. 2245-52.
13. Frayling, T.M., Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet, 2007. 8(9): p. 657-62.
14. Omori, S., et al., Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes, 2008. 57(3): p. 791-5.
15. Chen, L., et al., GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther, 2005. 312(2): p. 718-25.
16. DeFronzo, R.A., Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 1988. 37(6): p. 667-87.
17. I-Tsan Huang, M.D., Li-Jung Fang, M.D., M.P.H., Chun-Ping Huang, M.D., and M.D. Shih-Penn Hsu, Chun-Hong Chu, M.D., Gestational DiabetesMellitus in Taiwan. Taipei City Med J, 2005. 2(2): p. 132-137.
18. Fagot-Campagna, A., et al., Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr, 2000. 136(5): p. 664-72.
19. Weisz, O.A. and J.P. Johnson, Noncoordinate regulation of ENaC: paradigm lost? Am J Physiol Renal Physiol, 2003. 285(5): p. F833-42.
20. Karvonen, S., et al., Patterns of health-related behaviour and their cross-cultural validity--a comparative study on two populations of young people. Soz Praventivmed, 2000. 45(1): p. 35-45.
21. Green, A. and C.C. Patterson, Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia, 2001. 44 Suppl 3: p. B3-8.
22. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 2007. 447(7145): p. 661-78.
23. Ohshige, T., et al., A single nucleotide polymorphism in KCNQ1 is associated with susceptibility to diabetic nephropathy in japanese subjects with type 2 diabetes. Diabetes Care, 2010. 33(4): p. 842-6.
24. Tsai, F.J., et al., A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet, 2010. 6(2): p. e1000847.
25. Wen, J., et al., Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One, 2010. 5(2): p. e9153.
26. Rong, R., et al., Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes, 2009. 58(2): p. 478-88.
27. Omori, S., et al., Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals. Diabetologia, 2009. 52(8): p. 1554-60.
28. Sladek, R., et al., A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 2007. 445(7130): p. 881-5.
29. Ren, Q., et al., Exon sequencing and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a Chinese population. Diabetologia, 2008. 51(7): p. 1146-52.
30. Liu, Y., et al., Meta-analysis Added Power to Identify Variants in FTO Associated With Type 2 Diabetes and Obesity in the Asian Population. Obesity (Silver Spring), 2010.
31. Takeuchi, F., et al., Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes, 2009. 58(7): p. 1690-9.
32. Sanghera, D.K., et al., Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet, 2008. 9: p. 59.
33. Stolerman, E.S. and J.C. Florez, Genomics of type 2 diabetes mellitus: implications for the clinician. Nat Rev Endocrinol, 2009. 5(8): p. 429-36.
34. Cauchi, S., et al., Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One, 2008. 3(5): p. e2031.
35. Hu, C., et al., PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One, 2009. 4(10): p. e7643.
36. Miyake, K., et al., Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects. J Hum Genet, 2008. 53(2): p. 174-80.
37. Bressler, J., et al., Risk of type 2 diabetes and obesity is differentially associated with variation in FTO in whites and African-Americans in the ARIC study. PLoS One, 2010. 5(5): p. e10521.
38. Grant, S.F., et al., Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet, 2006. 38(3): p. 320-3.
39. Tong, Y., et al., Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet, 2009. 10: p. 15.
40. De Silva, N.M. and T.M. Frayling, Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits. Curr Opin Lipidol, 2010. 21(1): p. 44-50.
41. Neuman, R.J., et al., Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population. PLoS One, 2010. 5(3): p. e9903.
42. Luo, Y., et al., Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population. Diabetes Res Clin Pract, 2009. 85(2): p. 139-46.
43. Thomas, P.M., et al., Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science, 1995. 268(5209): p. 426-9.
44. Altshuler, D., et al., The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet, 2000. 26(1): p. 76-80.
45. Grant, R.W., A.F. Moore, and J.C. Florez, Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care, 2009. 32(6): p. 1107-14.
46. Kavale, K.A. and G.V. Glass, Meta-analysis and the integration of research in special education. J Learn Disabil, 1981. 14(9): p. 531-8.
47. Smith, M.L. and G.V. Glass, Meta-analysis of psychotherapy outcome studies. Am Psychol, 1977. 32(9): p. 752-60.
48. Ritchie, M.D., et al., Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet, 2001. 69(1): p. 138-47.
49. Harris, M.I., et al., Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care, 1997. 20(12): p. 1859-62.
50. Hansen, T., et al., The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care, 2007. 30(2): p. 257-62.
51. Matthews, D.R., et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985. 28(7): p. 412-9.
52. Barrett, J.C., et al., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 2005. 21(2): p. 263-5.
53. A haplotype map of the human genome. Nature, 2005. 437(7063): p. 1299-320.
54. Bell, P.A., et al., SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery. Biotechniques, 2002. Suppl: p. 70-2, 74, 76-7.
55. Purcell, S., S.S. Cherny, and P.C. Sham, Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics, 2003. 19(1): p. 149-50.
56. Perry, J.R. and T.M. Frayling, New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care, 2008. 11(4): p. 371-7.
57. Ruan, W. and M. Lai, Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome? Acta Diabetol, 2010. 47(1): p. 5-14.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/46358-
dc.description.abstract背景
基因遺傳與第2型糖尿病(Type 2 Diabetes)有顯著關聯性,近期的全基因組和候選基因關聯研究中更成功確定了高加索人種的潛在第2型糖尿病相關基因。為了降低第2型糖尿病相關基因研究中假陽性結果及了解不同族群間基因變異情形,我們針對20個與第2型糖尿病相關的基因在台灣的族群做再驗證實驗,並評估在第2型糖尿病相關基因的單獨變異及相互影響之間的關係以確定台灣族群中這些基因的作用點位與第2型糖尿病的相關性。
方法
本研究對象針對居住在台灣的漢人,包含1520個第2型糖尿病患實驗組及1520個正常對照組。進行ADAM30、NOTCH2、THADA、BCL11A、IGF2BP2、PPARG、ADAMTS9、WFS1、CDKAL1、VEGFA、JAZF1、SLC30A8、CDKN2A/B、HHEX、TCF7L2、EXT2、DCD、TSPAN8/LGR5、FTO、LOC387761 20個基因之基因定型,並分析對偶基因(Allele) 以及基因型(genotype)與其交互作用,對第2型糖尿病之相關性。
結果
研究20個與第2型糖尿病相關的基因,經過年齡,性別,身體質量指數調整後之統計分析,發現SLC30A8-rs13266643,風險值1.311(95%的信賴區間為1.176-1.461; p<0.0045);HHEX-rs1111875,風險值1.238(95%的信賴區間為1.103-1.389; p=0.0132)為台灣漢人第2型糖尿病的危險對偶基因。除此之外以基因計量分析檢測累積效應,結果顯示出累積>42個危險基因型比起<35的風險值為1.75(95%的信賴區間為1.39 to 2.20; P<0.001)。基因與基因的交互作用分析結果看出SLC30A8 及 CDKN2A之間的交互作用,在罹患第2型糖尿病上,高風險群基因型組合明顯比低風險高,其風險值為1.584(95%的信賴區間為1.372-1.828)。另外共8個基因多型性(SNP)在統合分析亞洲人與歐洲人(白人)的研究中被發現與第2型糖尿病具有意義之相關;此外本研究也發現10個SNP位點,在亞洲人與歐洲人(白人)有很強的異質性。
結論
我們的研究發現在從歐洲人(白人)的全基因研究所找出的20個基因中,在單一核苷酸多型性分析中,只有兩個被確定在台灣族群中與第2型糖尿病有顯著相關性,且在20個基因的危險對偶基因有很強的劑量效應。SLC30A8、CDKN2A的基因基因間交互作用或許可以做為將來第2型糖尿病臨床之參考。
zh_TW
dc.description.abstractBackground
There is a strong inheritable genetic connection in type 2 diabetes (T2D). Recently, a set of potential T2D genes in the Caucasian race have been successfully identified in several genome-wide and candidate gene association studies. In order to reduce the false-positive results of candidate genes studies and to understand the genetic variants of different races in T2D, we performed a replication study by genotyping 20 genetic variants which are in the most promising loci of Han Chinese of Taiwan to evaluate the individual and interacting effects of these variants in T2D. Based on the results, we could understand more about the roles of these candidate genes in T2D.
Methods
The study was comprised of 1520 type 2 diabetic cases and 1520 normoglycemic controls from Han Chinese of Taiwan. Then we performed a replication study by genotyping 20 genetic variants in the most promising loci, including ADAM30,NOTCH2,THADA,BCL11A,IGF2BP2,PPARG,ADAMTS9,WFS1,CDKAL1,VEGFA,JAZF1,SLC30A8,CDKN2A/B,HHEX,TCF7L2,EXT2,DCD,TSPAN8/LGR5,FTO and LOC387761. Allele and genotype of each SNP and their interactions were analyzed to assess the association with T2D.
Results
In single SNP association analysis, we replicated and confirmed 2 among the 20 genetic loci in association with T2D, with risk allele-specific odds ratios (ORs) of 1.311 (95% CI, 1.176-1.461; p<0.0045) for SLC30A8-rs13266643 and 1.238 (95% CI, 1.103-1.389; p=0.0132) for HHEX-rs1111875 after adjustment for age, gender, and body mass index, indicating that SLC30A8-rs13266643 and HHEX-rs1111875 are risk alleles of type 2 diabetes in Han Chinese in Taiwan. Besides, the result of gene-dose analysis to test cumulative effects, indicating that OR was 1.75 (95% confidence interval, 1.39 to 2.20; P<0.001) in subjects with risk alleles >42 compared with those with risk alleles <35.Gene-gene interaction analysis was carried out by means of the multifactor dimensionality reduction (MDR). This indicates that the high risk group had increased risk of T2D with OR1.584 (95%CI, 1.372-1.828), compared with the low risk group between SLC30A8 and CDKN2A . In meta-analyses, we found 8 SNPs were significantly associated with T2D in Asian and Caucasian population, and 10 SNPs showed marked heterogeneity between Asian and Caucasian populations.
Conclusions
We found that only two of the 20 T2D susceptibility genes identified by GWAS in Caucasian populations were confirmed to be T2D genes in our population. There is a cumulative effect of the risk alleles of these SNPs in association with T2D in Han Chinese in Taiwan. The SNP of the gene and gene-gene interaction between SLC30A8 and CDKN2A may be useful in clinical diagnosis of T2D in Taiwan.
en
dc.description.provenanceMade available in DSpace on 2021-06-15T05:05:13Z (GMT). No. of bitstreams: 1
ntu-99-P97448003-1.pdf: 2235747 bytes, checksum: 30007f9e162a6551a1a50235331a637d (MD5)
Previous issue date: 2010
en
dc.description.tableofcontents口試委員會審定書
誌謝
中文摘要…………………………………………………………………I
英文摘要………………………………………………………………III
目錄………………………………………………………………………V
表目錄…………………………………………………………………VII
圖目錄…………………………………………………………………VIII
第一章.前言………………………………………………………………1
1.1研究背景………………………………………………………………1
1.2研究目的………………………………………………………………1
第二章.文獻探討…………………………………………………………3
2.1糖尿病的定義…………………………………………………………3
2.2糖尿病之臨床分類……………………………………………………3
2.3第2型糖尿病之發生率………………………………………………4
2.4回顧全基因組關聯研究genome-wide association………………4
2.5統合分析(meta-analysis)…………………………………………7
2.6基因-基因交互作用分析……………………………………………8
第三章.研究方法與材料…………………………………………………9
3.1個案收集………………………………………………………………9
3.2各項生化指標檢查……………………………………………………9
3.3血液之Genomic DNA萃取……………………………………………9
3.4基因單一核甘酸多型性(SNP)之選擇……………………………10
3.5基因型之檢定………………………………………………………11
3.6統計分析方法………………………………………………………14
3.6.1賽仕(SAS)統計……………………………………………………14
3.6.2利用HaploView運算haplotype…………………………………15
3.6.3 Genetic Power Calculator計算power值……………………15
3.6.4統合分析(meta-analysis)………………………………………15
3.6.5基因計量分析(Gene-dose analysis)…………………………15
3.6.6基因-基因交互作用分析…………………………………………15
第四章.結果……………………………………………………………17
4.1個案基本資料………………………………………………………17
4.2單一基因之邏輯回歸分析…………………………………………17
4.3 Haplotype與第2型糖尿病相關基因之相關性分析………………17
4.4 Genetic Power Calculator………….…………………………18
4.5 GWAS與此次實驗結果之統合性分析………………………………18
4.6累積效應(Cumulative effects)………………………………18
4.7進行「multifactor dimensionality reduction (MDR)」探討多個基因-基因的交互作用與疾病的關聯性
…………………………………………………………………………19
第五章.討論……………………………………………………………21
第六章.結論……………………………………………………………24
第七張 圖表……………………………………………………………27
參考文獻…………………………………………………………………51
附錄………………………………………………………………………55
dc.language.isozh-TW
dc.title全基因組關聯研究所發現之第2型糖尿病基因的再驗證研究zh_TW
dc.titleA Replication Study of Genetic Variants in Genes Identified by Genome-wide Association Study in Type 2 Diabetesen
dc.typeThesis
dc.date.schoolyear98-2
dc.description.degree碩士
dc.contributor.oralexamcommittee呂勝春(Sheng-Chung Lee),蘇怡寧
dc.subject.keyword第2型糖尿病,全基因組研究,再驗證研究,統合分析,異質性,zh_TW
dc.subject.keywordType 2 diabetes (T2D),genome-wide association studies(GWAS),replication study,meta-analysis,heterogeneity,en
dc.relation.page60
dc.rights.note有償授權
dc.date.accepted2010-07-27
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept分子醫學研究所zh_TW
顯示於系所單位:分子醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-99-1.pdf
  目前未授權公開取用
2.18 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved